Cargando…

The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study

PURPOSE: The absolute benefit of adjuvant chemotherapy in stage II CRC is only 3–4%. The identification of biomarkers through molecular profiling could identify patients who will more benefit from adjuvant chemotherapy. PATIENTS AND METHODS: This retrospective analysis examined tissue blocks from 17...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberto, Michela, Arrivi, Giulia, Pilozzi, Emanuela, Montori, Andrea, Balducci, Genoveffa, Mercantini, Paolo, Laghi, Andrea, Ierinò, Debora, Panebianco, Martina, Marinelli, Daniele, Tomao, Silverio, Marchetti, Paolo, Mazzuca, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000544/ https://www.ncbi.nlm.nih.gov/pubmed/35418781 http://dx.doi.org/10.2147/CMAR.S342612

Ejemplares similares

The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets
por: Roberto, Michela, et al.
Publicado: (2023)

Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN(®) System Comprehensive Approach
por: Roberto, Michela, et al.
Publicado: (2021)

Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center
por: Magi, Ludovica, et al.
Publicado: (2019)

Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

Laparoscopic versus open rectal resection: a 1:2 propensity score–matched analysis of oncological adequateness, short- and long-term outcomes
por: Garbarino, Giovanni Maria, et al.
Publicado: (2021)

Profiling the Prognosis of Gastric Cancer Patients: Is It Worth Correlating the Survival with the Clinical/Pathological and Molecular Features of Gastric Cancers?
por: Lorenzon, Laura, et al.
Publicado: (2013)

How technology can help in oncologic patient management during COVID-19 outbreak
por: Mercantini, Paolo, et al.
Publicado: (2020)

Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
por: Roberto, Michela, et al.
Publicado: (2021)

The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management
por: Roberto, Michela, et al.
Publicado: (2023)

Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
por: Crimini, Edoardo, et al.
Publicado: (2019)

Electrochemotherapy for Solid Tumors: Literature Review and Presentation of a Novel Endoscopic Approach
por: Schipilliti, Francesca Matilde, et al.
Publicado: (2022)

Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study
por: Mazzuca, Federica, et al.
Publicado: (2019)

Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer
por: Roberto, Michela, et al.
Publicado: (2020)

CT based radiomic approach on first line pembrolizumab in lung cancer
por: Zerunian, Marta, et al.
Publicado: (2021)

D1-plus vs D2 nodal dissection in gastric cancer: a propensity score matched comparison and review of published literature
por: Lorenzon, Laura, et al.
Publicado: (2020)

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
por: Rossi, Luigi, et al.
Publicado: (2013)

Clinico-pathological Features of Colon Cancer Patients Undergoing Emergency Surgery: A Comparison Between Elderly and Non-elderly Patients
por: Costa, Gianluca, et al.
Publicado: (2019)

The Emergency Surgery Frailty Index (EmSFI): development and internal validation of a novel simple bedside risk score for elderly patients undergoing emergency surgery
por: Costa, Gianluca, et al.
Publicado: (2020)

Robotic versus open oncological gastric surgery in the elderly: a propensity score-matched analysis
por: Garbarino, Giovanni Maria, et al.
Publicado: (2020)

A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Bassanelli, Maria, et al.
Publicado: (2021)

Commentary on “A Case of Paratesticular Leiomyosarcoma Successfully Treated with Orchiectomy and Chemotherapy”
por: Virgilio, Edoardo, et al.
Publicado: (2016)

Non-operative management of blunt splenic injury: is it really so extensively feasible? a critical appraisal of a single-center experience
por: Fransvea, Pietro, et al.
Publicado: (2019)

The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
por: Roberto, Michela, et al.
Publicado: (2021)

Risk of coronavirus disease 2019 in patients treated for cancer: An immune response–based hypothesis
por: Roberto, Michela, et al.
Publicado: (2020)

Albumin-bound formulation of paclitaxel (Abraxane(®) ABI-007) in the treatment of breast cancer
por: Miele, Evelina, et al.
Publicado: (2009)

Somatic NGS Analysis of DNA Damage Response (DDR) Genes ATM, MRE11A, RAD50, NBN, and ATR in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemo-Radiotherapy
por: Montori, Andrea, et al.
Publicado: (2022)

Low Anterior Resection Syndrome (LARS) after Surgery for Rectal Cancer: An Inevitable Price to Pay for Survival, or a Preventable Complication?
por: Muttillo, Edoardo Maria, et al.
Publicado: (2023)

The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression
por: Roberto, Michela, et al.
Publicado: (2017)

Short tandem repeat profiling for the authentication of cancer stem‐like cells
por: Visconti, Paola, et al.
Publicado: (2020)

Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives
por: Barchiesi, Giacomo, et al.
Publicado: (2021)

An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report)
por: Panebianco, Martina, et al.
Publicado: (2021)

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment
por: Botticelli, Andrea, et al.
Publicado: (2016)

Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines
por: Mazzuca, Federica, et al.
Publicado: (2018)

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience
por: Valeriani, Maurizio, et al.
Publicado: (2019)

Immune effects of CDK4/6 inhibitors in patients with HR(+)/HER2(−) metastatic breast cancer: Relief from immunosuppression is associated with clinical response
por: Scirocchi, Fabio, et al.
Publicado: (2022)

Arginine-Specific Mono ADP-Ribosylation In Vitro of Antimicrobial Peptides by ADP-Ribosylating Toxins
por: Castagnini, Marta, et al.
Publicado: (2012)

Clinical management of endoscopically resected pT1 colorectal cancer
por: Antonelli, Giulio, et al.
Publicado: (2018)

A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
por: Tomao, Silverio, et al.
Publicado: (2006)

Radiomic Cancer Hallmarks to Identify High-Risk Patients in Non-Metastatic Colon Cancer
por: Caruso, Damiano, et al.
Publicado: (2022)

RE: Atypical Pulmonary Metastases from Pancreatic Adenocarcinoma
por: Virgilio, Edoardo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qhv4bp8nqbchh0l7g26beijdj6